Jazz Pharmaceuticals Public Limited Company (JAZZ)
-NasdaqGS 62.78 
2.78(4.63%) 10:32AM EDT - Nasdaq Real Time Price
| Prev Close: | 60.00 |
|---|
| Open: | 60.30 |
|---|
| Bid: | 62.12 x 100 |
|---|
| Ask: | 62.20 x 100 |
|---|
| 1y Target Est: | 74.77 |
|---|
| Beta: | 0.87 |
|---|
| Next Earnings Date: | 9-Aug-13 |
|---|
| Day's Range: | 60.30 - 62.85 |
|---|
| 52wk Range: | 40.38 - 62.85 |
|---|
| Volume: | 724,015 |
|---|
| Avg Vol (3m): | 766,839 |
|---|
| Market Cap: | 3.69B |
|---|
| P/E (ttm): | 12.46 |
|---|
| EPS (ttm): | 4.99 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Jazz Reaches New 52-Week High (JAZZ)at TheStreet(Wed 10:14AM EDT)
- Jazz Pharmaceuticals Public Limited Company Presents at UBS Global Healthcare Conference, May-21-2013 09:30 AMat Seeking Alpha(Tue, May 21)
- Elan Provides Strategic UpdateZacks(Tue, May 21)
- FDA Accepts Actavis NDAZacks(Mon, May 20)
- 3 Value Investing Plays in Health Careat Motley Fool(Thu, May 16)
- Good News for Novartis' IlarisZacks(Wed, May 15)
- Nektar Posts Wider Loss, Maintains ViewZacks(Wed, May 15)
- Synergy Pharma Posts Wider LossZacks(Wed, May 15)
- Dr. Reddy's Earnings Increase Y/YZacks(Wed, May 15)
- 3 Stocks to Get on Your Watchlistat Motley Fool(Wed, May 15)
- JAZZ PHARMACEUTICALS PLC FinancialsEDGAR Online Financials(Tue, May 14)
- Forest-Trevena Ink DealZacks(Tue, May 14)
- Jazz Pharma Posts Higher Y/Y EarningsZacks(Tue, May 14)
- Jazz Pharmaceuticals Announces Participation In Upcoming Investor EventsPR Newswire(Mon, May 13)
- Teva - Alexza Sign Deal for AdasuveZacks(Mon, May 13)
Key Statistics
| Forward P/E (1 yr): | 8.28 |
|---|
| P/S (ttm): | 5.20 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 6.15 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 1.52 |
|---|
| Mean Recommendation*: | 1.5 |
|---|
| PEG Ratio (5 yr expected): | 0.53 |
|---|
Business Summary
Jazz Pharmaceuticals Public Limited Company, a specialty biopharmaceutical company, engages in the identification, development, and commercialization of pharmaceutical products for various medical needs in the United States, Europe, and other coun...
View More